A retrospective, observational study to describe the proportion of patients who achieve platelet counts [plts] ≥30,000/µl within 12 weeks of Thrombopoietin-Receptor Agonists initiation in the management of Immune Thrombocytopenia
Latest Information Update: 19 Jan 2019
At a glance
- Drugs Eltrombopag (Primary) ; Romiplostim (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- Acronyms TRAIT
Most Recent Events
- 19 Jan 2019 New trial record
- 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology